Table 4.
Participants' characteristics in studies.
| Study ID | Diseases | Age Mean (SD) | Sex | Baseline characteristics Mean (SD) |
|---|---|---|---|---|
| Gunn et al. (2016) | AMC (27), CP (5), MD (8), SMA (9), others (6) | 9 (6) | — | — |
| Shank (2017) | AMC (14), CP (3), MD (2), SMA (2), others (4) | 8 (1) | 9 F, 16 M | — |
| van der Heide and de Witte (2016) | ALS (1), MD (1), MS (3), SCI (1), SMA (8), others (5) | 55 (15) | 11 F, 8 M | 3.4 (1.7) points in Brooke scale |
| Peters et al. (2017) | Stroke (18) | 56 (12) | 7 F, 11 M | — |
| Rahman et al. (2007) | MD (10), SMA (3) | 13 (4) | 1 F, 12 M | 3.3 (0.7) points in MMT |
| Iwamuro et al. (2008) | Chronic hemiparesis after stroke (10) | 58 (14) | 5 F, 5 M | — |
| Estilow et al. (2018) | DMD (9) | 15 (2) | 9 M | 4.5 (0.7) points in Brooke scale |
| Jan Burgers (2015) | DMD (8) | 15 (3) | 8 M | 3.8 (1.0) points in Brooke scale |
| Lund et al. (2009) | ALS (2), AMC (1), MD (2), SMA (2) | — | 5 F, 2 M | — |
| Sanchez et al. (2004) | Chronic stroke (5) | — | — | — |
| van der Heide et al. (2017) | ALS (1), MD (1), SCI (1), Stroke (1), others (1) | 52 (15) | 3 F, 2 M | 3.4 (0.9) points in Brooke scale |
| Bastiaens et al. (2011) | MS (4) | 57 (8) | — | 35.8 (20.8) points in MI |
| Ambrosini et al. (2014) | SCI (3) | 51 (19) | 3 M | 43.7 (15.8) points in MI |
| Kooren et al. (2015) | DMD (3) | 15 (2) | 3 M | 2.6 (0.6) points in Brooke scale |
AMC, Arthrogryposis Multiplex Congenital; ALS, Amyotrophic Lateral Sclerosis; CP, Cerebral Palsy; DMD, Duchenne Muscular Dystrophy; MD, Muscular Dystrophy; MS, Multiple Sclerosis; SCI, Spinal Cortex Injury; SMA, Spinal Muscular Atrophy; M, Male; F, Female; MMT, Manual Muscle Test; MI, Motricity Index.